CD19 and acute lymphoblastic leukemia: Anti-CD19 CAR T-cells expressing a N-terminal modified (N9del) PSMA, engineered to prevent internalisation and intracellular signalling which may affect cell physiology, have been tracked in a model of acute lymphoblastic leukaemia using [18F]DCFPyL [47].